Advanced search

In vivo evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies

(2005) NUCLEAR MEDICINE AND BIOLOGY. 32(2). p.193-200
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Staelens, Ludovicus, Ruth Oltenfreiter, Filip Dumont, RN WATERHOUSE, K VANDENBULCKE, PETER BLANCKAERT, Rudi Dierckx, and Guido Slegers. 2005. “In Vivo Evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a Potential Sigma Receptor Ligand for SPECT Studies.” Nuclear Medicine and Biology 32 (2): 193–200.
APA
Staelens, Ludovicus, Oltenfreiter, R., Dumont, F., WATERHOUSE, R., VANDENBULCKE, K., BLANCKAERT, P., Dierckx, R., et al. (2005). In vivo evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies. NUCLEAR MEDICINE AND BIOLOGY, 32(2), 193–200.
Vancouver
1.
Staelens L, Oltenfreiter R, Dumont F, WATERHOUSE R, VANDENBULCKE K, BLANCKAERT P, et al. In vivo evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies. NUCLEAR MEDICINE AND BIOLOGY. ELSEVIER SCIENCE INC; 2005;32(2):193–200.
MLA
Staelens, Ludovicus, Ruth Oltenfreiter, Filip Dumont, et al. “In Vivo Evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a Potential Sigma Receptor Ligand for SPECT Studies.” NUCLEAR MEDICINE AND BIOLOGY 32.2 (2005): 193–200. Print.
@article{307744,
  author       = {Staelens, Ludovicus and Oltenfreiter, Ruth and Dumont, Filip and WATERHOUSE, RN and VANDENBULCKE, K and BLANCKAERT, PETER and Dierckx, Rudi and Slegers, Guido},
  issn         = {0969-8051},
  journal      = {NUCLEAR MEDICINE AND BIOLOGY},
  language     = {eng},
  number       = {2},
  pages        = {193--200},
  publisher    = {ELSEVIER SCIENCE INC},
  title        = {In vivo evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies},
  volume       = {32},
  year         = {2005},
}

Web of Science
Times cited: